Abstract:
Techniques, systems computer program products are disclosed increasing tagging efficiency in velocity selective arterial spin labeling using multiple velocity selective saturation modules. In one aspect, a magnetic resonance imaging method for tagging arterial blood includes using two or more velocity selective saturation (VSS) modules to tag arterial blood. The tagged arterial blood is imaged.
Abstract:
Aspects of embodiments relate to methods of treating human immunodeficiency virus (HIV) infection. Further aspects of embodiments also relate to constellations of compositions for treating HIV infection. Still additional aspects of embodiments relate to a many methods of making compositions useful in the treatment of HIV infection.
Abstract:
Techniques, systems computer program products are disclosed for mapping of vascular perfusion territories by applying a train of pseudo-continuous radio frequency tagging pulses to modulate a first magnetization of one or more blood vessels that supply blood to one or more vascular perfusion territories, applying an encoding scheme using unipolar transverse gradient pulses to modulate a second magnetization of blood vessels of the vascular perfusion territories, obtaining efficiency for each blood vessel based on the applied encoding scheme and separating the vascular perfusion territories by using the obtained tagging efficiency in a decoding process.
Abstract:
Techniques, systems computer program products are disclosed increasing tagging efficiency in velocity selective arterial spin labeling using multiple velocity selective saturation modules. In one aspect, a magnetic resonance imaging method for tagging arterial blood includes using two or more velocity selective saturation (VSS) modules to tag arterial blood. The tagged arterial blood is imaged.
Abstract:
Techniques, systems computer program products are disclosed for mapping of vascular perfusion territories by applying a train of pseudo-continuous radio frequency tagging pulses to modulate a first magnetization of one or more blood vessels that supply blood to one or more vascular perfusion territories, applying an encoding scheme using unipolar transverse gradient pulses to modulate a second magnetization of blood vessels of the vascular perfusion territories, obtaining efficiency for each blood vessel based on the applied encoding scheme and separating the vascular perfusion territories by using the obtained tagging efficiency in a decoding process.
Abstract:
The present invention is directed to methods of diagnosing and treating a fibrotic condition in a mammalian subject. These methods involve measuring the levels of trimethylation at lysine residue 27 of histone-3 and/or measuring the expression levels of EZH2 or YY-1. Agents useful for treating fibrosis or a fibrotic condition are also disclosed.
Abstract:
This invention provides a process for sequencing nucleic acids using 3' modified deoxynucleotide analogues or 3' modified deoxyinosine triphosphate analogues, and 3' modified dideoxynucleotide analogues having a detectable marker attached thereto.
Abstract:
Techniques, systems computer program products are disclosed for mapping of vascular perfusion territories by applying a train of pseudo-continuous radio frequency tagging pulses to modulate a first magnetization of one or more blood vessels that supply blood to one or more vascular perfusion territories, applying an encoding scheme using unipolar transverse gradient pulses to modulate a second magnetization of blood vessels of the vascular perfusion territories, obtaining efficiency for each blood vessel based on the applied encoding scheme and separating the vascular perfusion territories by using the obtained tagging efficiency in a decoding process.
Abstract:
Aspects of embodiments relate to methods of treating human immunodeficiency virus (HIV) infection. Further aspects of embodiments also relate to constellations of compositions for treating HIV infection. Still additional aspects of embodiments relate to a many methods of making compositions useful in the treatment of HIV infection.